Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Celularity Inc.

Celularity Inc. (CELUW) Stock Overview

Explore Celularity Inc.’s financial performance, market position, analyst ratings, and future outlook.

CELUW●NASDAQ
HealthcareBiotechnology
$0.002
$0.002(533.33%)
U.S. Market is Open · 15:00

Celularity Inc. (CELUW)

Meyka AI Score

Z

Key Financials

Market Cap19.5M
P/E Ratio-0.21
EPS (TTM)$-2.75
ROE4.11%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year Target$0.00

CELUW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Celularity Inc. (NASDAQ: CELUW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Celularity Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CELUW on the NASDAQ shows an RSI of 42.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Celularity Inc.'s NASDAQ-traded stock include a P/E ratio of -0.21 and a market capitalization of 19.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CELUW on the NASDAQ.

Price Performance (NASDAQ: CELUW)

1-Day Change
533.33%
5-Day Change
-78.16%
1-Month Change
-62.00%
3-Month Change
-78.16%
6-Month Change
-89.73%
Year-to-Date (YTD) Change
-88.31%
1-Year Change
-96.19%
3-Year Change
-96.45%
5-Year Change
-99.90%
All-Time (Max) Change
-99.68%

Contact Information

https://www.celularity.com
908 768 2170
170 Park Avenue, Florham Park, NJ, 07932

Company Facts

1,150 Employees
IPO DateJul 19, 2021
CountryUS
Actively Trading

Frequently Asked Questions